EORTC/LinkedIn
Jun 11, 2025, 09:13
EORTC Launches DE-ESCALATE Phase III Trial For Metastatic Prostate Cancer
EORTC – European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:
“This Men’s Health Awareness Week, we’re proud to mark the official launch of the DE-ESCALATE Project, a pragmatic Phase III clinical trial focusing on metastatic prostate cancer.
DE-ESCALATE is one of three research projects coordinated by EORTC, alongside the LEGATO Project and the STREXIT 2 Project, which have received funding from the Horizon Europe Programme. The study is in collaboration with Syreon Research Institute and will have a duration of five years.
Read the article to learn more.”
More posts featuring EORTC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 20, 2025, 20:20
Jul 20, 2025, 20:10
Jul 20, 2025, 19:54
Jul 20, 2025, 19:20
Jul 20, 2025, 18:59
Jul 20, 2025, 18:27
Jul 20, 2025, 18:12
Jul 20, 2025, 17:37